SSYS earnings call summary

Prepared Highlights

• 总营收1.327亿美元，同比下滑约2.4%（CFO）
• 产品营收8,880万美元（去年9,380万），其中系统营收2,880万（去年3,120万），耗材营收6,000万（去年6,260万）（CFO）
• 服务营收4,390万美元（去年4,220万），其中客户支持营收2,970万（去年3,000万）（CFO）
• Stratasys Direct部门扣除剥离后有机增长23%，环比增长超10%（CEO/CFO）
• GAAP毛利率41.7%（去年44.3%），非GAAP毛利率46.3%（去年48.3%），同比变化主要因关税增量240万美元影响180个基点（CFO）
• GAAP运营亏损2,650万美元（去年亏损1,240万）；非GAAP运营亏损320万（去年运营收入300万）（CFO）
• 调整后EBITDA为200万美元（去年820万），汇率与关税合计影响约530万（CFO）
• 运营现金流240万美元，期末现金及短期存款2.378亿美元，无债务（CFO）
• 入选美国国防部“联合增材制造可接受性IV试点零件计划”（Gamma 4），为百万美元级项目（CEO）
• TrueDent树脂获CE Class IIa医疗器械认证，为首个欧洲该级别彩色3D打印义齿方案，目标市场2028年达24.5亿美元（CEO）
• ULTEM 1010树脂现可用于F3300打印机，TUF1材料扩展至J3与J5系列（CEO）
• 2026年营收指引5.65亿至5.75亿美元，预计每季度环比增长，耗材收入全年将超过2025年水平（CFO）

Official guidance

• 2026全年营收预期：5.65亿美元至5.75亿美元，每季度环比增长，耗材收入全年将超过2025年（CFO）

Mgmt quotes

• “Our first quarter results reflect the continued resilience of our operating model in a measured spending environment.”（CEO）
• “Recurring revenue streams from consumables and customer support continues to provide stability, while printer purchasing time lines remained extended.”（CEO）
• “This is not prototype stage or pilot stage engagement. This is production scale additive manufacturing at operational tempo for the most demanding customers in the world.”（CEO）
• “We maintained adjusted EBITDA profitability and generated positive operating cash flow, outcomes that reflect both the structural improvement embedded in our cost model and the stability of our recurring revenue base.”（CFO）
• “We are reiterating the full year guidance we provided on our last call. Revenues are expected to range between $565 million to $575 million, growing sequentially each quarter through the year.”（CFO）

Prepared Metrics

Q&A Batch (1–4 of 4)

Q1 — Jackson Schroeder

• Topic: Defense opportunity beyond drones; JAMA IV and munitions replenishment
• Key points:
  • Aerospace & defense is a leading vertical with “very promising pipeline”; transformation is global (US, Germany, Japan).
  • US DoD budget request for 2027 is ~$1.5 trillion (+45% YoY); $75 billion earmarked for advanced digital manufacturing.
  • Stratasys Direct grew 23% YoY, led by drones but also munitions, sustainment, and shipyard tooling.
  • Examples include parts for missiles, large UAVs using FDM F900/F3300 with ULTEM materials, and sustainment for aging aircraft (e.g., KC-135).
• Mgmt stance: Bullish – strong existing relationships (US Dept of War, NAVAIR, Air Force, large OEMs) and proven part-printing indicator for future system sales.

Q2 — Trevor Sahr

• Topic: Production vs. prototyping in A&D; dental market opportunity in Europe
• Key points:
  • A&D focus is on production: drone dominance, sustainment, maritime/shipyard catch-up. “Majority of this demand is production part, not prototypes.”
  • Stratasys Direct ships over 100,000 production parts annually; also strong demand for tooling for depot/shipyard line renewal.
  • European dental market (removables) projected at $2.45 billion by 2028; Stratasys has first-mover advantage with TrueDent (Class IIa certified, polychromatic dentures).
  • Dental solves labor shortage and reduces dentist chair time; US market for removables is ~$5 billion.
• Mgmt stance: Bullish – production-based demand is “never seen before” in defense; dental strategy is established with leading US players (Affordable, Glidewell) and expanding into Europe.

Q3 — Alek Valero

• Topic: TrueDent certification timing; large tech company F3300 update; guidance reaffirmation
• Key points:
  • European dental projection ($2.45B by 2028) is from analyst reports; US removables market is ~$5 billion.
  • TrueDent certification opens new applications (partial dentures, crown & bridges); first-mover advantage emphasized.
  • Large tech company that bought F3300s (mentioned two quarters ago) – “unfortunately, we cannot share” details.
  • Q1 is softer; H1 softer than H2; H2 is “definitely defense driven.” Company maintains guidance and is “on plan” – first year of growth in three years.
• Mgmt stance: Bullish – progressing according to growth plan; transition from prototyping to manufacturing is working.

Q4 — Kieran McCabe

• Topic: Stratasys Direct as indicator for system sales inflection; inorganic opportunities
• Key points:
  • Parts business (STM) is a precursor to OEM system sales; Q1 organic growth 23% supports confidence in H2 hardware growth.
  • Q2 2026 expected revenue similar to Q2 2025 levels (i.e., flat YoY).
  • Strong balance sheet: no debt, cash on hand; targeting inorganic opportunities in “high requirement applications” (e.g., defense, dental).
  • Strategy is to avoid low-value prototyping and “race to the bottom” – focus on high-end, high-requirement use cases.
• Mgmt stance: Bullish – balance sheet enables value-accretive M&A; parts business signals future system sales; disciplined capital allocation strategy.